Abstract
Various N-α-hydroxyalkyl derivatives of N-acyl amino acids and di- and tripeptides were prepared by hydrolysis or aminolysis of N-acyl 5-oxazolidinones. The stability of these derivatives was studied in aqueous solution as a function of pH. The compounds were all degraded quantitatively to their parent N-acylated amino acid or peptide and aldehyde but with vastly different rates. At pH 7.4 and 37°C the half-lives of decomposition ranged from 4 min to 1500 hr. The structural factors influencing the stability included both steric and polar effects within the acyl and N-α-hydroxyalkyl moieties as well as within the amino acid attached to the N-α-hydroxyalkylated N-acyl amino acid. Whereas the N-benzyloxycarbonyl (Z) derivatives of the dipeptides Gly-L-Leu and Gly-L-Ala were readily hydrolyzed by carboxypeptidase A, the N-hydroxymethylated compounds, i.e., Z-Gly(CH2OH)-Leu and Z-Gly(CH2OH)-Ala, were resistant to cleavage by the enzyme as revealed by their similar rates of decomposition in the presence or absence of the enzyme at pH 7.4 and 37°C. The results suggest that N-α-hydroxyalkylation of a peptide bond protects not only this bond but also an adjacent peptide bond against proteolytic cleavage. Since the N-α-hydroxyalkyl derivatives are readily bioreversible, undergoing spontaneous hydrolysis at physiological pH, this prodrug approach promises to overcome the enzymatic barrier to absorption of various peptides.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
K. Wiedhaup. The stability of small peptides in the gastrointestinal tract. In D. D. Breimer and P. Speiser (eds.), Topics in Pharmaceutical Sciences, Elsevier, Amsterdam, 1981, pp. 307–324.
M. J. Humphrey and P. S. Ringrose. Peptides and related drugs: A review of their absorption, metabolism and excretion. Drug Metabl. Rev. 17:283–310 (1986).
V. H. L. Lee and A. Yamamoto. Penetration and enzymatic barriers to peptide and protein absorption. Adv. Drug Deliv. Rev. 4:171–207 (1990).
H. Bundgaard. Bioreversible derivatizaiton of peptides. In S. S. Davis, L. Illum, and E. Tomlinson (eds.), Delivery Systems for Peptide Drugs, Plenum Press, New York, 1986, pp. 49–68.
U. Klixbüll and H. Bundgaard. Prodrugs as drug delivery systems. 30.4-Imidazolidinones as potential bioreversible derivatives for the α-aminoamide moiety in peptides. Int J Pharm. 20:273–284 (1984).
A. Buur and H. Bundgaard. Prodrugs of peptides. III. 5-Oxazolidinones as bioreversible derivatives for the α-amido carboxy moiety in peptides. Int. J. Pharm. 46:159–167 (1988).
H. Bundgaard and J. Møss. Prodrugs of peptides. IV. Bioreversible derivatization of the pyroglutamyl group by N-acylation and N-aminomethylation to effect protection against pyroglutamyl aminopeptidase. J. Pharm. Sci. 78:122–126 (1989).
H. Bundgaard and J. Møss. Prodrug derivatives of thyrotropin-releasing hormone and other peptides. Biochem. Soc. Trans. 17:947–949 (1989).
J. Møss and H. Bundgaard. Prodrugs of peptides. 5. Protection of the pyroglutamyl residue against pyroglutamyl aminopeptides by bioreversible derivatization with glyoxylic acid derivatives. Int. J. Pharm. 52:255–263 (1989).
H. Bundgaard and J. Møss. Prodrugs of peptides. 6. Bioreversible derivatives of thyrotropin-releasing hormone (TRH) with increased lipophilicity and resistance to cleavage by the TRH-specific serum enzyme. Pharm. Res. 7:885–892 (1990)
J. Møss and H. Bundgaard. Prodrugs of peptides. 7. Transdermal delivery of thyrotropin-releasing hormone (TRH) via prodrugs. Int. J. Pharm. 66:39–45 (1990).
P. S. Farmer. Bridging the gap between bioactive peptides and nonpeptides: some perspectives in design. In E. J. Ariëns (ed.), Drug Design, Vol. X, Academic Press, London, 1980, pp 119–143.
B. E. B. Sandberg C.-M. Lee, M. R. Hanley, and L. L. Iversen. Synthesis and biological properties of enzyme-resistant analogues of substance P. Eur. J. Biochem. 114:329–337 (1981).
S. Thaisrivongs, D. T. Pals, D. W. Harris, W. M. Kati, and S. R. Turner. Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo. J. Med. Chem. 29:2088–2093 (1986).
D. F. Veber and R. M. Freidinger. The design of metabolicallystable peptide analogs. Trends Neurosci. 8:392–396 (1985).
J.-L. Fauchère. Elements for the rational design of peptide drugs. Adv. Drug Res. 15:29–69 (1986).
M. Johansen and H. Bundgaard. Prodrugs as drug delivery systems. VI. Kinetics and mechanism of the decomposition of N-hydroxymethylated amides and imides in aqueous solution and assessment of their suitability as possible prodrugs. Arch. Pharm. Chem. Sci. Ed. 9:40–42 (1981).
H. Bundgaard and M. Johansen. Prodrugs as drug delivery systems. VIII. Bioreversible derivatization of hydantoins by N-hydroxymethylation. Int. J. Pharm. 5:67–77 (1980).
H. Bundgaard and M. Johansen. Hydrolysis of N-(α-hydroxy-benzyl)benzamide and other N-(α-hydroxyalkyl)-amide derivatives: Implications for the design of N-acyloxyalkyl-type prodrugs. Int. J. Pharm. 22:45–56 (1984).
H. Bundgaard. Design of prodrugs: Bioreversible derivatives for various functional groups and chemical entities. In H. Bundgaard (ed.), Design of Prodrugs, Elsevier, Amsterdam, 1985, pp. 1–92.
D. Ben-Ishai. Reaction of acylamino acids with paraformaldehyde. J. Org. Chem. 79:5736–5738 (1957).
F. Micheel and W. Meckstroth. Peptidsynthesen nach dem Oxazolidon-Verfahren. III. Chem. Ber. 92:1675–1679 (1959).
M. Johansen, H. Bundgaard, and E. Falch. Spectrophotometric determination of the rates of hydrolysis of aldehyde-releasing pro-drugs in aqueous solution and plasma. Int. J. Pharm. 13:89–98 (1983).
H. S. Harned and W. J. Hamer. The ionization constant of water in potassium chloride solution from electromotive forces of cells without liquid junctions. J. Am. Chem. Soc. 53:2194–2206 (1933).
F. Micheel and S. Thomas. Eine neue Peptid-Synthese. Chem. Ber. 90:2906–2909 (1957).
E. Dane, R. Heiss, and H. Schäfer. Peptid-Synthesen unter Verwendung von Chloral. Angew. Chem. 71:339 (1959).
M. Itoh. Peptides. I. Selective protection of α-or side-chain carboxyl groups of aspartic and glutamic acid. A facile synthesis of β-aspartyl and γ-glutamyl peptides. Chem. Pharm. Bull. 17:1679–1686 (1969).
J. Ugelstad and J. de Jonge. A kinetical investigation of the reaction between amides and formaldehyde. Rec. Trav. Chem. 76:919–945 (1957).
H. Bundgaard and A. Buur. Prodrugs as drug delivery systems. 65. Hydrolysis of α-hydroxy-and α-acyloxy-N-benzoylglycine derivatives and implications for the design of prodrugs of NH-acidic compounds. Int. J. Pharm. 37:185–194 (1987).
H. Bundgaard and M. Johansen. Pro-drugs as drug delivery systems. X. N-Mannich bases as novel pro-drug candidates for amides, imides, urea derivatives, amines and other NH-acidic compounds. Kinetics and mechanisms of decomposition and structure-activity relationships. Arch. Pharm. Chem. Sci. Ed. 8:29–52 (1980).
M. Charton. The prediction of chemical lability through substituent effects. In E. B. Roche (ed.), Design of Biopharmaceutical Properties Through Prodrugs and Analogs, American Pharmaceutical Association, Washington, D.C., 1977, pp. 228–280.
M. Johansen and H. Bundgaard. Decomposition of rolitetracy-cline and other N-Mannich bases and of N-hydroxymethyl derivatives in the presence of plasma. Arch. Pharm. Chem. Sci. Ed. 9:40–42 (1981).
E. L. Smith. The specificity of certain peptidases. Adv. Enzymol. 12:191–257 (1951).
J. A. Hartsuck and W. N. Lipscomb. Carboxypeptidase A. In P. D. Boyer (ed.), The Enzymes, Vol. III, Academic Press, New York, 1971. pp. 1–56.
M. A. Stahmann, J. S. Fruton, and M. Bergmann. The specificity of carboxypeptidase. J. Biol. Chem. 164:753–760 (1946).
H. T. Hanson and E. L. Smith. The application of peptides containing β-alanine to the study of the specificity of various peptidases. J. Biol. Chem. 175:833–848 (1948).
J. E. Snoke and H. Neurath. Structural requirements of specific substrates for carboxypeptidases. J. Biol. Chem. 181:789–802 (1949).
D. M. Blow. The structure of chymotrypsin. In P. D. Boyer (ed.), The Enzymes, Vol. III, Academic Press, New York, 1971, pp. 185–212.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bundgaard, H., Rasmussen, G.J. Prodrugs of Peptides. 9. Bioreversible N-α-Hydroxyalkylation of the Peptide Bond to Effect Protection Against Carboxypeptidase or Other Proteolytic Enzymes. Pharm Res 8, 313–322 (1991). https://doi.org/10.1023/A:1015833229554
Issue Date:
DOI: https://doi.org/10.1023/A:1015833229554